Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 1;59(9):2308-2315.
doi: 10.1093/rheumatology/kez589.

All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type

Zachary S Wallace  1   2   3   4 , Xiaoqing Fu  1   2   3 , Tyler Harkness  1   2   3 , John H Stone  2   3   4 , Yuqing Zhang  1   2   3   4 , Hyon Choi  2   3   4
Affiliations

All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type

Zachary S Wallace et al. Rheumatology (Oxford). .

Abstract

Objective: The objective of this study was to evaluate causes of death in a contemporary inception cohort of ANCA-associated vasculitis patients, stratifying the analysis according to ANCA type.

Methods: We identified a consecutive inception cohort of patients newly diagnosed with ANCA-associated vasculitis from 2002 to 2017 in the Partners HealthCare System and determined vital status through the National Death Index. We determined cumulative mortality incidence and standardized mortality ratios (SMRs) compared with the general population. We compared MPO- and PR3-ANCA+ cases using Cox regression models.

Results: The cohort included 484 patients with a mean diagnosis age of 58 years; 40% were male, 65% were MPO-ANCA+, and 65% had renal involvement. During 3385 person-years (PY) of follow-up, 130 patients died, yielding a mortality rate of 38.4/1000 PY and a SMR of 2.3 (95% CI: 1.9, 2.8). The most common causes of death were cardiovascular disease (CVD; cumulative incidence 7.1%), malignancy (5.9%) and infection (4.1%). The SMR for infection was greatest for both MPO- and PR3-ANCA+ patients (16.4 and 6.5). MPO-ANCA+ patients had an elevated SMR for CVD (3.0), respiratory disease (2.4) and renal disease (4.5). PR3- and MPO-ANCA+ patients had an elevated SMR for malignancy (3.7 and 2.7). Compared with PR3-ANCA+ patients, MPO-ANCA+ patients had a higher risk of CVD death [hazard ratio 5.0 (95% CI: 1.2, 21.2]; P = 0.03].

Conclusion: Premature ANCA-associated vasculitis mortality is explained by CVD, infection, malignancy, and renal death. CVD is the most common cause of death, but the largest excess mortality risk in PR3- and MPO-ANCA+ patients is associated with infection. MPO-ANCA+ patients are at higher risk of CVD death than PR3-ANCA+ patients.

Keywords: ANCA-associated vasculitis; cardiovascular disease; cause of death; mortality.

PubMed Disclaimer

Figures

<sc>Fig</sc>. 1
Fig. 1
All-cause mortality in the Partners ANCA-associated vasculitis cohort
<sc>Fig</sc>. 2
Fig. 2
Cumulative incidence of CVD-specific mortality in MPO- vs PR3-ANCA+ ANCA-associated vasculitis
See this image and copyright information in PMC

References

    1. Tan JA, Dehghan N, Chen W. et al. Mortality in ANCA-associated vasculitis: a meta-analysis of observational studies. Ann Rheum Dis 2017;76:1566–74. - PubMed
    1. Tan JA, Choi HK, Xie H. et al. All-cause and cause-specific mortality in granulomatosis with polyangiitis: a population-based study. Arthritis Care Res 2019;71:155–63. - PubMed
    1. Luqmani R, Suppiah R, Edwards CJ. et al. Mortality in Wegener’s granulomatosis: a bimodal pattern. Rheumatology 2011;50:697–702. - PubMed
    1. Holle JU, Gross WL, Latza U. et al. Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 2011;63:257–66. - PubMed
    1. Wallace ZS, Lu N, Unizony S, Stone JH, Choi HK.. Improved survival in granulomatosis with polyangiitis: a general population-based study. Semin Arthritis Rheum 2016;45:483–9. - PMC - PubMed

Publication types

MeSH terms